Identification and characterization of two unusual cGMP-stimulated phoshodiesterases in Dictyostelium by Bosgraaf, L et al.
  
 University of Groningen
Identification and characterization of two unusual cGMP-stimulated phoshodiesterases in
Dictyostelium
Bosgraaf, L; Russcher, H; Snippe, H; Bader, S; Wind, J; Van Haastert, PJM
Published in:
Molecular Biology of the Cell
DOI:
10.1091/mbc.E02-05-0302
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2002
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Bosgraaf, L., Russcher, H., Snippe, H., Bader, S., Wind, J., & Van Haastert, PJM. (2002). Identification and
characterization of two unusual cGMP-stimulated phoshodiesterases in Dictyostelium. Molecular Biology of
the Cell, 13(11), 3878-3889. https://doi.org/10.1091/mbc.E02-05-0302
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Molecular Biology of the Cell
Vol. 13, 3878–3889, November 2002
Identification and Characterization of Two Unusual
cGMP-stimulated Phoshodiesterases in Dictyostelium
Leonard Bosgraaf, Henk Russcher, Helena Snippe, Sonya Bader, Joyce
Wind, and Peter J.M. Van Haastert*
Department of Biochemistry, University of Groningen, 9747 AG Groningen, The Netherlands
Submitted May 27, 2002; Revised July 30, 2002; Accepted August 19, 2002
Monitoring Editor: Peter N. Devreotes
Recently, we recognized two genes, gbpA and gbpB, encoding putative cGMP-binding proteins
with a Zn2-hydrolase domain and two cyclic nucleotide binding domains. The Zn2-hydrolase
domains belong to the superfamily of -lactamases, also harboring a small family of class II
phosphodiesterases from bacteria and lower eukaryotes. Gene inactivation and overexpression
studies demonstrate that gbpA encodes the cGMP-stimulated cGMP-phosphodiesterase that was
characterized biochemically previously and was shown to be involved in chemotaxis. cAMP
neither activates nor is a substrate of GbpA. The gbpB gene is expressed mainly in the multicellular
stage and seems to encode a dual specificity phosphodiesterase with preference for cAMP. The
enzyme hydrolyses cAMP 9-fold faster than cGMP and is activated by cAMP and cGMP with
a KA value of 0.7 and 2.3 M, respectively. Cells with a deletion of the gbpB gene have increased
basal and receptor stimulated cAMP levels and are sporogeneous. We propose that GbpA and
GbpB hydrolyze the substrate in the Zn2-hydrolase domain, whereas the cyclic nucleotide
binding domains mediate activation. The human cGMP-stimulated cAMP/cGMP phosphodies-
terase has similar biochemical properties, but a completely different topology: hydrolysis takes
place by a class I catalytic domain and GAF domains mediate cGMP activation.
INTRODUCTION
cAMP and cGMP are important signaling molecules in pro-
karyotes and eukaryotes. These molecules are produced by
cyclases, degraded by phosphodiesterases, and exert their
functions by binding to specific proteins. In prokaryotes,
cAMP regulates gene expression via binding to the cyclic
nucleotide binding (cNB) domain of catabolic repressor tran-
scription factors (Passner et al., 2000). In eukaryotes, cAMP
and cGMP regulate enzyme and channel activity mainly
through protein kinases, RapGEFs, or channels (Houslay
and Milligan, 1997; Lohmann et al., 1997; De Rooij et al., 1998;
Kraemer et al., 2001). In addition to this large family of
cAMP/cGMP binding proteins, some phosphodiesterases
contain a GAF domain, which is an unrelated cGMP-binding
domain that regulates enzyme activity (Francis et al., 2000).
cAMP is probably present in all eukaryotes and cAMP-
dependent protein kinase is a universal target even in prim-
itive eukaryotes. Much less is known about the synthesis
and function of cGMP in the lower eukaryotes. Yeast seems
to lack cGMP, because the genome of Saccharomyces cerevisiae
does not provide indications for putative guanylyl cyclases
or cGMP-binding domains. Guanylyl cyclases have been
identified in Paramecium, Tetrahymena, and Plasmodium, but
the role of cGMP in these organisms is not yet resolved
(Linder et al., 1999; Carucci et al., 2000).
In Dictyostelium, cAMP has an extracellular function as
chemoattractant and an intracellular function as inducer of
development (Reymond et al., 1995). Extracellular cAMP
binds to G protein-coupled receptors, which results in the
activation of several signaling systems, including adenylyl
cyclase, guanylyl cyclase, phosphatidylinositol 3-kinase, and
calcium channels (Van Haastert and Kuwayama, 1997; Par-
ent and Devreotes, 1999; Chung et al., 2001). The produced
intracellular cAMP is partly secreted where it activates
neighboring cells. Intracellular cAMP may also bind to the
regulatory subunit of cAMP-dependent protein kinase, me-
diating gene regulation and development. Eventually,
cAMP is degraded by the extracellular phosphodiesterase
PsdA (Lacombe et al., 1986) and by the intracellular phos-
phodiesterase RegA (Shaulsky et al., 1998; Thomason et al.,
1998).
Activation of the cAMP receptor also results in the tran-
sient activation of guanylyl cyclases. The produced cGMP is
rapidly degraded, mainly by a cGMP-stimulated cGMP-
specific phosphodiesterase (Ross and Newell, 1981; Van
Haastert et al., 1982b). As a consequence of the brief activa-
Article published online ahead of print. Mol. Biol. Cell 10.1091/
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tion of guanylyl cyclases and the substrate stimulation of
phosphodiesterase activity, the cGMP accumulation has the
shape of a spike with a maximum at 10 s and recovery of
basal levels after 30 s. The function of cGMP in Dictyostelium
probably concentrates on chemotaxis and osmoregulation,
as was suggested by mutants defective in cGMP metabolism
(Kuwayama et al., 1993, 1996). Mutant stmF lacks the cGMP-
stimulated phosphodiesterase (PDE) activity, whereas mu-
tant KI8 shows very low levels of guanylyl cyclase activity.
The genes defective in these mutants have not been identi-
fied.
To understand the function of cGMP in Dictyostelium it is
essential to identify the genes that encode cGMP-metaboliz-
ing enzymes and cGMP target proteins. Recently, we char-
acterized two unusual guanylyl cyclases in Dictyostelium,
GCA and sGC, that are not related to vertebrate guanylyl
cyclases, but are homologous to 12-transmembrane and sol-
uble adenylyl cyclase, respectively (Roelofs et al., 2001a,b). In
addition, four genes were identified, named gbpA-gbpD,
which possess putative cNB domains (Goldberg et al., 2002).
GbpC and GbpD are likely to mediate cGMP functions,
because these proteins contain Ras, Kinase, and RasGEF
domains besides the two putative cGMP-binding domains.
Previous experiments have shown that Dictyostelium con-
tains a cGMP-stimulated cGMP-phosphodiesterase (Van
Haastert et al., 1982a; Coukell et al., 1984). We speculated that
the cGMP-stimulated cGMP-phosphodiesterase is encoded
by GbpA or GbpB, because these proteins contain a putative
cGMP-binding domain and a Zn2-binding hydrolase do-
main that is distantly related to a small family of class II
phosphodiesterases (Carfi et al., 1995). We have inactivated
the four gbp genes and analyzed the resulting cell lines for
myosin phosphorylation and chemotaxis (Bosgraaf et al.,
2002). The experiments identified a cGMP-signaling cascade
in which G protein-coupled receptors stimulate two novel
guanylyl cyclases. The produced cGMP is transduced via
GbpC to regulate myosin phosphorylation and assembly in
the cytoskeleton, which are critical for chemotaxis. GbpA
and GbpB were shown to be involved in the degradation of
cGMP (Bosgraaf et al., 2002). Herein, we report on the char-
acterization of GbpA as the cGMP-stimulated cGMP-specific
phosphodiesterase absent in mutant stmF, whereas GbpB
seems to be a phosphodiesterase with dual specificity with
respect to substrate and activation by both cAMP and
cGMP.
MATERIALS AND METHODS
Strain and Culture Conditions
AX3 (“wild-type”), DH1 (an uracil auxotroph wild-type, kindly
provided by P.N. Devreotes; Johns Hopkins Medical School, Balti-
more, MD), and the mutant cell lines described below were grown
in HG5 medium (HL5 with 10 g/l glucose) to a density of 2  106
cells/ml. When grown with selection, HG5 medium was supple-
mented with 10 g/ml blasticidine S. Starved cells were obtained by
shaking for 4–5 h in 10 mM phosphate buffer (PB), pH 6.5, at a
density of 107 cells/ml. Tight aggregates were obtained by starving
the cells on nonnutrient agar for10 h; aggregates were collected in
PB, washed by centrifugation, and disrupted to small cell clumps by
passing the aggregates 10 times through a 0.5  16-mm needle.
Gene Disruption
The disruptant strains were obtained as described previously (Bos-
graaf et al., 2002). Briefly, a 468-base pair genomic fragment of gbpA
was obtained by polymerase chain reaction (PCR) by using primers
TCATAGATCTAGAAGGTGATTATACAG and AGTTGGATC-
CATTGTTGCTAATTC. The PCR product was subcloned, and the
Bsr selection cassette (Sutoh, 1993) was cloned into the MslI site of
the genomic fragment. To disrupt the gbpB gene, a PCR product of
900 base pairs was amplified using the primers CCATTCTATGT-
GAAGTCAATC and AATTACTACTTACCAGCACC. The pyr5/6
cassette was cloned in the BclI restriction site. The selection cassette
with gbp flanking sequences was amplified by PCR and5 g of the
PCR product was used to transform Dictyostelium DH1 cells. To
select for transformants with the bsr cassette, HG5 was supple-
mented with 10 g/ml blasticidin, whereas transformants with the
pyr5/6 cassette were selected using uracil-deficient FM medium
(Bio 101, Vista, CA). Potential knockouts were screened by PCR and
confirmed by Southern analysis.
Overexpression of GbpB in Dictyostelium
The full-length copy of gbpB without introns was obtained from
cDNA fragments and PCR products. The gbpB sequence started
with AGATCTAAAAATGAATTCTAAATAT (the BglII restriction
site underlined and the start codon in bold), whereas the sequences
had a BamHI restriction site engineered after the stop codon. The
DNA was sequenced to verify the absence of mutations. The BglII/
BamHI fragment of full-length gbpB was cloned in the BglII site of
plasmid AH2 and transformed to gbpA/gbpB double-null cells.
Plasmid AH2 is derivative of the extrachromosomal plasmid
MB12neo (Heikoop et al., 1998), except that the Neo selection and
gene expression cassettes contain the actin8 terminator.
Phosphodiesterase Assay of Dictyostelium Lysates
Cells were washed twice with PDE lysis buffer (40 mM HEPES/
NaOH, pH 7.0, 0.5 mM EDTA) and resuspended at a density of 108
cells/ml in PDE lysis buffer supplemented with 0.25 M sucrose.
Cells were lysed by passage through a 0.45-m Nuclepore filter. The
lysate was centrifuged for 2 min at 14,000  g and the supernatant
was used.
The PDE assay mixture (final concentrations) contained assay
buffer (40 mM HEPES/NaOH, pH 7.0, 0.5 mM EDTA, 0.25 M
sucrose, 5 mM MgCl2), 10 nM [3H]cAMP, or 10 nM [3H]cGMP as
substrate, 5 mM dithiothreitol to inhibit the very active PDE1, and
30 l of lysate in a total volume of 100 l; the lysates were diluted
to achieve between 10 and 30% hydrolysis of substrate. After incu-
bation for 15 min at 22°C, reactions were terminated by boiling for
1 min. The product was dephosphorylated by calf intestine phos-
phatase (1 unit of enzyme in 100 l of CIP buffer incubated for 1 h
at 37°C). Finally, 300 l of a 50% slurry of DOWEX AG1X2 was
added to remove remaining substrate. After 15-min incubation at
22°C, samples were centrifuged for 2 min at 14,000  g, and the
radioactivity in 200 l of the supernatant was determined.
cAMP and cGMP Responses
Cells were starved for 5 h in PB, washed, and resuspended in PB to
a density of 108 cells/ml. For determination of the cGMP response,
cells were stimulated with 0.1 M cAMP and lysed at the times
indicated by the addition of an equal volume of 3.5% (vol/vol)
perchloric acid. Cells were stimulated with 10 M 2deoxy-cAMP
and 10 mM dithiotreitol for induction of the cAMP response. Ly-
sates were neutralized with KHCO3, and cGMP and cAMP levels
were determined by isotope dilution assays by using a cGMP-
specific antibody or the regulatory subunit of cAMP-dependent
protein kinase, respectively.
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Spore Formation
The assay for induction of spore formation is essentially as de-
scribed previously (Shaulsky et al., 1998; Thomason et al., 1998).
Cells were washed and resuspended to a density of 4 105 cells/ml
in spore buffer (10 mM MES, 10 mM NaCl, 10 mM KCl, 1 mM CaCl2,
1 mM MgSO4, pH 6.5), and 500 l of the suspension was added to
a well of a 24-well plate, yielding a density of 105 cells/cm2. Cells
were incubated in the absence or presence of 5 mM cAMP or 20 M
Sp-cAMPS. After 36 h, when some spore-like cells were observed in
some incubations, the buffer was replaced by PB with 0.5% (vol/vol)
NP-40 to kill remaining amoebae. After 15 min at 22°C, samples
were centrifuged for 3 min at 1000  g, the pellet was washed twice
with PB, and resuspended in 100 l of PB. The number of viable
spores was determined by plating 2 l of the suspension in associ-
ation with Klepsiella aerogenes. The number of colonies was deter-
mined three days later, and could be maximally 4000 if all amoebae
were retrieved and converted to viable spores.
RESULTS
Topology of GbpA and GbpB
GbpA and GbpB are both composed of two potential cNB
domains and one Zn2-binding domain (Figure 1). The
alignment of the four cNB domains, together with the cNB
domains of bacterial CAP protein, Drosophila protein kinase
G (PKG), Dictyostelium protein kinase A (PKA), Caenorhab-
ditis elegans cyclic nucleotide regulated channel, and Epac
are presented in Figure 2A. The Dictyostelium cNB domains
of GbpA and GbpB comply reasonably well with the con-
sensus sequence, but are more divergent than for instance
the cNB domains of Dictyostelium cAMP-dependent PKA. In
the crystal structure of the CAP protein (Passner et al., 2000),
cAMP interacts mainly with the amino acids IGEL and
RSAxV (Figure 2A). In PKA, the amino acid at the position
of the serine in RSA is an alanine, whereas in PKG this
amino acid is a threonine and mutagenesis to alanine pro-
vides cAMP binding (Shabb et al., 1991). This region is
Figure 1. GbpA and GbpB. GbpA and GbpB have the same do-
main topology; a Zn2-hydrolase putative catalytic domain and two
cNB domains. The asterisks indicate the position of disruption in the
knockout cell lines. The topology of the cGMP-stimulated cAMP/
cGMP phosphodiesterase from human (HsPDE) is shown for com-
parison; this enzyme has the same biochemical properties as GbpA,
but is composed of a class I PDE domain and two cGMP-binding
GAF domains.
Figure 2. Sequence alignment. (A) Alignment of the four cNB domains from GbpA and GbpB with the cNB domains from Drosophila PKG,
Dictyostelium regulatory subunit of PKA, human Epac, Escherichia coli CAP, and a C. elegans cyclic nucleotide-gated channel. The consensus
is based on the alignment of 140 cNB domains; a black background indicates amino acids conserved in 80% of the sequences and a gray
background in 60% of the sequences. The consensus sequence refers to hydrophobic (h), polar (o), small (s), and negatively charged ()
amino acids, or to specific amino acids (capital letters). The asterisks (*) denote the amino acids that have been shown to interact with cAMP
in the CAP crystal structure (Passner et al., 2000). (B) Alignment of the putative Zn2-binding motifs of two Zn2-hydrolase domains from
GbpA and GbpB with those from Dictyostelium -lactamase (Dd-BLA), Bacillus cereus -lactamase (Bc-BLA), human glyoxalase (Hs-GLO2),
Vibrio fischeri phosphodiesterase (Vf-PDE), Schizosaccharomyces pombe phosphodiesterase (Sp-PDE), and Dictyostelium phosphodiesterase
(Dd-PDE1). The consensus is based on 98 sequences with gray scales indicating conserved amino acids in 95% (black) or 80% (gray) of
the sequences. The asterisks (*) indicates amino acids that are conserved in class II PDEs but are variant in GbpA and GbpB.
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relatively poorly conserved in GbpA and GbpB, especially in
the second cNB domains. The first cNB domains of both
GbpA and GbpB possess a serine at the position of RTA,
which may suggest that the first cNB domains more likely
bind cGMP than cAMP. However, the cNB domains of
GbpA and GbpB are also homologous to CAP proteins,
which bind cAMP and cGMP with similar affinity and con-
tain a serine at this position.
The Zn2-binding domains of GbpA and GbpB show a
high degree of identity to each other (44% identity) and
belong to the superfamily of -lactamases with a metal-
dependent hydrolase fold (Figure 2B). This domain is char-
acterized by conserved histidines and aspartates that are
also present in GbpA and GbpB. The superfamily of Zn2-
binding domains contains many hydrolases such as -lacta-
mases, glyoxalases, and class II cyclic nucleotide phosphodi-
esterases (Carfi et al., 1995). SMART and Pfam programs
recognize the Zn2-binding domains of GbpA and GbpB as
-lactamases, but not as class II phosphodiesterases. The
alignment reveals several amino acids that are conserved in
class II phosphodiesterases, but not in GbpA and GbpB
(Figure 2B, asterisks). Also phylogenetic analysis indicates
that the Zn2-binding domains of GbpA and GbpB are more
closely related to the -lactamases than to the monophyletic
group of class II phosphodiesterases (our unpublished data).
GbpA Encodes a cGMP-stimulated cGMP-specific
Phosphodiesterase
To investigate the function of GbpA and GbpB, Dictyostelium
cells were transformed with knockout constructs. Clones
were screened by PCR for putative knockout strains and
confirmed by Southern blots (data not shown). In this way,
three cell lines were obtained with single and double knock-
outs of the gbp genes. The expression of gbpA and gbpB in
knockout strains was investigated using Northern blots,
demonstrating the absence of expression of even a truncated
messenger in the knockout strains (data not shown).
The main cGMP-phosphodiesterase activity in Dictyoste-
lium can be stimulated by the analog 8-bromo-cGMP (Van
Haastert et al., 1982b). To test whether the cGMP-stimulated
cGMP-phosphodiesterase is encoded by gbpA and/or gbpB,
we measured cGMP-phosphodiesterase activity in the ab-
sence and presence of 8-bromo-cGMP in the gbp null
strains. High levels of cGMP-PDE activity were found in
wild-type cells, and this activity was stimulated two- to
threefold by 8-bromo-cGMP (Figure 3). This enzyme activity
was also present at high levels in gbpB null cells, indicating
that gbpB does not encode the enzyme. In contrast, cGMP-
phosphodiesterase activity was very low in gbpA null cells,
and this small activity was not stimulated by 8-bromo-
cGMP. The residual activity in gbpA cells had the kinetic
properties of DdPDE3 (low KM value and inhibition by
isobutylmethylxanthine; our unpublished data; Kuwayama
et al., 2001). The double mutant gbpA/gbpB had a similar
low cGMP-phosphodiesterase activity as gbpA. These re-
sults indicate that gbpA encodes the well-characterized
cGMP-stimulated cGMP-phosphodiesterase activity in Dic-
tyostelium and that gbpB may encode a phosphodiesterase
with different biochemical properties.
GbpB May Encode a Dual Specificity
Phosphodiesterase Stimulated by cGMP and cAMP
Northern blots reveal that gbpB is expressed maximally in
the multicellular stage (Goldberg et al., 2002). Therefore, we
measured phosphodiesterase activity in lysates prepared
from tight aggregates. Phosphodiesterase activity of gbpA
null cells is composed of several (partly unknown) phos-
phodiesterases except GbpA, whereas gbpA/gbpB cells
possess the same mixture of enzymes except GbpA and
GbpB. Thus, by subtracting the activity of gbpA/gbpB
lysates from gbpA lysates, information on GbpB is ob-
tained. Similarly, the difference of enzyme activity between
gbpB and gbpA/gbpB yields the biochemical properties of
GbpA. Assays were conducted with [3H]cAMP or
[3H]cGMP as substrate in the absence or presence of 8-bro-
mo-cAMP or 8-bromo-cGMP as activators (Figure 4).
The lysates prepared from tight aggregates of gbpA/
gbpB double null cells contain a small cGMP- and cAMP-
hydrolyzing activity that is not affected by 8-bromo-cAMP
or 8-bromo-cGMP. GbpA is characterized by the additional
activity in gbpB cells, demonstrating cGMP-hydrolyzing
activity that is stimulated fourfold by 8-bromo-cGMP; 8-bro-
mo-cAMP has no effect, and cAMP is not a substrate. These
deduced properties of GbpA in tight aggregates are essen-
tially identical to those of GbpA in aggregation-competent
cells described above. GbpB was characterized using gbpA
cells, showing a small cGMP- and a larger cAMP-hydrolyz-
ing activity on top of the cGMP- and cAMP-hydrolyzing
activity of gbpA/gbpB double-null cells. This activity is
stimulated by both 8-bromo-cAMP and 8-bromo-cGMP.
These findings suggest that GbpB might be a dual specificity
phosphodiesterase, both in respect to the substrate as well as
the activator. However, the activity is rather low for a full
Figure 3. cGMP-PDE activity in vegetative gbp null cells. The
hydrolysis of 10 nM [3H]cGMP in the absence (black bar) or pres-
ence of 1 M 8-bromo-cGMP (hatched bar) was measured in the
supernatant of a lysate prepared from 2-h starved wild-type DH1
cells (WT), gbpA cells (A), gbpB cells (B), and the double-null
gbpA/gbpB cells (AB). The results shown are the means and
SDs of three independent experiments with triplicate determina-
tions and reveal a loss of 8-bromo-cGMP–stimulated phosphodies-
terase activity in gbpA cells.
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biochemical characterization of GbpB, and therefore we
overexpressed GbpB in Dictyostelium.
Overexpression of GbpB in Dictyostelium gbpA/
gbpB Cells
GbpB was expressed in growing cells from a strong actin
promoter by using the extrachromosomal expression vector
AH2. We used the double null gbpA/gbpB as host to have
a null background of GbpA and GbpB enzyme activity. The
lysates of gbpA/gbpB/GbpBOE cells contain cAMP- and
cGMP-hydrolyzing activity that is much higher that the
activity observed in lysates from gbpA/gbpB cells (Figure
5). The increase of cAMP-hydrolyzing activity is 15 pmol/
min/mg protein, which is 60-fold higher than the esti-
mated endogenous GbpB activity of wild-type cells at 10 nM
cAMP (0.26 pmol/min/mg protein; Table 2). Overexpres-
sion of GbpB provides a much smaller increase of cGMP-
hydrolyzing activity (1.6 pmol/min/mg protein above the
activity in gbpA/gbpB cells), indicating that GbpB is 9-
fold more active toward cAMP than toward cGMP. Both the
cAMP- and cGMP-hydrolyzing activity are stimulated1.5-
fold by 1 M 8-bromo-cGMP and 8-bromo-cAMP. These
data on overexpressed GbpB confirm the provisional con-
clusions on phosphodiesterase activity in tight aggregates of
gbpA that GbpB is a dual-specificity phosphodiesterase
with preference for cAMP.
Biochemical Properties of GbpA and GbpB
The biochemical properties of GbpB were determined using
the gbpA/gbpB/GbpBOE cells (Figure 6). The hydrolysis of
10 nM [3H]cAMP or 10 nM [3H]cGMP was measured in the
absence or presence of different concentrations of cAMP or
cGMP, respectively. Figure 6A demonstrates that low con-
centrations of cAMP stimulate the hydrolysis of 10 nM
[3H]cAMP, whereas concentrations above 10 M cAMP in-
hibit the hydrolysis of [3H]cAMP. For the hydrolysis of 10
nM [3H]cGMP we observed similar properties: stimulation
at low concentrations of cGMP and inhibition at high cGMP
concentrations. These data were used to obtain the activa-
tion constant KA, the Michaelis-Menten constant KM, and the
VMAX of GbpB. Figure 6B demonstrates that cAMP and
cGMP stimulate the enzyme maximally 1.5- and 1.9-fold,
respectively. The KA value is 0.71 M for cAMP and 2.3 M
for cGMP. The data on the hydrolysis of cAMP and cGMP
are presented as Eady-Hofstee plot in Figure 6C, demon-
strating activation at low concentrations and linear curves at
higher concentrations. The slopes of the linear parts yield a
KM value of 200 M for cAMP and 800 M for cGMP,
whereas the intercepts with the abscissa yield a VMAX value
of 650 and 300 nmol/min/mg protein for cAMP and cGMP,
respectively.
The biochemical properties of GbpA were derived from a
partially purified enzyme from wild-type cells (Van Haas-
tert and Van Lookeren Campagne, 1984) by using the same
analysis as for GbpB. The enzyme preparation does not
show hydrolysis of [3H]cAMP, indicating that cAMP hydro-
lysis is at least 100-fold slower than cGMP. Figure 7A reveals
that low concentrations of cGMP stimulate the hydrolysis of
[3H]cGMP, whereas concentrations above 1 M inhibit the
hydrolysis of [3H]cGMP; cAMP does not activate the hydro-
lysis of [3H]cGMP but inhibits at very high concentrations
with a KI value of 1.8 mM. The activation constant KA of
GbpA for cGMP is 0.16 M, and the enzyme is activated
Figure 4. cGMP and cAMP PDE activity in tight aggregate gbp
null. Cells were starved and developed on nonnutrient agar until
the tight aggregate stage, collected, dissociated, and lysed. The
hydrolysis of 10 nM [3H]cGMP or [3H]cAMP was measured in the
absence (black bar) or presence of 1 M 8-bromo-cGMP (cross-
hatched bar) or 8-bromo-cAMP (striped bar) in the supernatant of a
lysate prepared from gbpA cells (A), gbpB cells (B), and the
double-null gbpA/gbpB cells (AB). The difference in activities
between AB and A characterizes GbpB, whereas the difference
between AB and B provides information of GbpA. The results
confirm the observations in Figure 3 that GbpA encodes a cGMP-
stimulated cGMP-PDE, and suggest that GbpB hydrolyzes cAMP
and perhaps cGMP and is activated by both 8-bromo-cAMP and
8-bromo-cGMP.
Figure 5. Overexpression of GbpB in gbpA/gbpB cells The hy-
drolysis of 10 nM [3H]cGMP or [3H]cAMP was measured in the
absence (black bar) or presence of 1 M 8-bromo-cGMP (cross-
hatched bar) or 8-bromo-cAMP (striped bar) in the supernatant of a
lysate prepared from gbpA/gbpB cells (AB) and from gbpA/
gbpB/GbpBOE (BOE). The results demonstrate that GbpB hydrolyses
cAMP 8-fold faster than cGMP; both 8-bromo-cAMP and 8-bro-
mo-cGMP activate the enzyme.
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maximally 2.4-fold (Figure 7B). The Eady-Hofstee plot re-
veals a Michaelis-Menten constant KM value for cGMP of 5.2
M.
In summary, GbpA and GbpB are novel cyclic nucleotide
stimulated cyclic nucleotide phosphodiesterases. GbpA is a
cGMP-specific enzyme, whereas GbpB is a dual specificity
enzyme with preference for cAMP. Activation of GbpB oc-
curs at higher cGMP concentrations than activation of GbpA
and does not discriminate between cAMP and cGMP; in
contrast, activation of GbpA is at least 300-fold more specific
for cGMP than for cAMP.
cGMP Response in gbpA and gbpB Mutants
The consequences of deletion of gbpA and gbpB on basal
cGMP levels and on the cAMP-mediated cGMP response of
5-h starved cells are presented in Figure 8A. Basal cGMP
levels in wild-type cells are 1 pmol/107 cells that increase
to 6 pmol/107 cells upon stimulation with cAMP; maximal
levels are obtained after 10 s, and basal levels are recovered
after 30 s. Deletion of the cGMP-stimulated cGMP-PDE in
gbpA cells leads to an increase of basal cGMP levels from 1
to 3 pmol/107 cells. The cAMP-mediated cGMP response is
enlarged from 6 to 15 pmol/107 cells; the cGMP accumu-
lation continues and persists for a longer period than in
wild-type cells, causing the cGMP peak to occur at 20 s; basal
levels are recovered after 120 s. The altered cGMP re-
sponse in gbpA cells is essentially identical to the cGMP
response in the mutant stmF, which also lacks the cGMP-
stimulated cGMP-PDE (Van Haastert et al., 1982a).
Disruption of gbpB has only a small effect on cGMP levels
(Figure 8B); basal levels and the cGMP response are in-
creased by 25% relative to wild-type cells, confirming the
relatively small contribution of GbpB to the total cGMP-PDE
activity in vivo. The potential cGMP-hydrolyzing activity of
GbpB can be demonstrated in a gbpA null cells, which lack
the major cGMP-PDE activity. Disruption of gbpB in a gbpA
background results in a further increase of basal cGMP
levels from 3 pmol/107 cells in gbpA to 12 pmol/107 cells in
gbpA/gbpB. The cAMP-induced cGMP response is also
substantially enhanced and prolonged from a maximum of
15 pmol/107cells at 20 s after stimulation in gbpA to 40
pmol/107 cells at 30 s after stimulation in the gbpA/gbpB
strain; basal levels were reached after3–4 min (Figure 8A).
These results demonstrate that the low cGMP-PDE activity
of GbpB becomes functionally significant when the much
more active cGMP-PDE activity of GbpA is deleted.
Overexpression of GbpB in gbpA/gbpB cells whips out
the dramatic cGMP response seen in the gbpA/gbpB cells
Figure 6. Characterization of GbpB. A lysate was prepared from gbpA/gbpB/GbpBOE cells and incubated with 10 nM [3H]cGMP or
[3H]cAMP in the presence of different concentrations of unlabeled cGMP or cAMP, respectively. The effect of unlabeled cAMP () or cGMP
(Œ) on the hydrolysis of the radioactive tracer is presented in A. These data are converted in panel B (see Van Haastert and Van Lookeren
Campagne, 1984); vo is the hydrolysis in the absence and v in the presence of the indicated concentrations of unlabeled substrate [S]. The plot
allows the determination of the activation constant KA (intercept abscissa is1/KA) and the maximal fold activation AMAX (intercept ordinate
is 1/(AMAX  1)). The data of A were also used for an Eady-Hofstee plot (C) to calculate the KM value of the activated enzyme (slope is
1/KM) and VMAX (intercept ordinate). The obtained kinetic data are listed in Table 2.
Figure 7. Characterization of GbpA. A partially purified preparation of GbpA was prepared from wild-type cells and incubated with 10 nM
[3H]cGMP in the presence of different concentrations of unlabeled cGMP (Œ) or cAMP (). The enzyme preparation does not show detectable
hydrolysis of [3H]cAMP, indicating that cAMP is hydrolyzed at least 100-fold slower than cGMP. The kinetic constants for cGMP were
derived from the plots in B and C, as described in Figure 6, and are listed in Table 2.
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(Figure 8B). Basal cGMP levels are 1.1 pmol/107 cells in
the overexpressor strain relative to 12 pmol/107 cells in the
parental gbpA/gbpB cells and 1 pmol/107 cells in wild-
type cells. The cGMP response is also substantially reduced
to 1.5 pmol/107 cells, which is even much lower than the
cGMP response of wild-type cells.
cAMP Response in gbpA and gbpB Mutants
Stimulation of aggregation-competent cells with cAMP in-
duces a transient accumulation of intracellular cAMP. In
wild-type cells 50% of the produced cAMP is secreted and
50% is degraded intracellularly (Dinauer et al., 1980). We
stimulated cells with 2-deoxy-cAMP and dithiotreitol and
measured the accumulation of cAMP in the cell suspension.
The analog 2-deoxy-cAMP binds to surface cAMP receptor
with high affinity but does not interfere with the determina-
tion of cAMP levels. Dithiotreitol inhibits the surface and
extracellular PDE activity encoded by the psdA gene, but has
no effect on GbpA or GbpB (our unpublished data). Thus, in
this experiment we detect receptor-stimulated cAMP forma-
tion that eventually accumulates in the extracellular me-
dium; the data below are presented for 107 cells. Basal cAMP
levels of wild-type cells is 2.6  0.5 pmol (Figure 8C);
2-deoxy-cAMP induces the accumulation of cAMP at an
initial rate of 0.35  0.06 pmol/s, and the final increase of
(extracellular) cAMP is 18.7  1.1 pmol above basal levels.
Deletion of the cAMP-PDE in gbpB cells leads to an in-
crease of basal cAMP levels to 4.6  0.7 pmol. The 2-deoxy-
cAMP–mediated increase of cAMP levels shows approxi-
mately the same initial rate as in wild-type cells (0.38  0.10
pmol/s), but continues for a longer period by which even-
tually1.6-fold more cAMP accumulates in the extracellular
medium (28.2 4.4 pmol). Basal cAMP levels and the cAMP
response in gbpA/gbpB cells are essentially identical to the
response seen in gbpB cells. The normal initial cAMP ac-
cumulation rate in gbpB and gbpA/gbpB cells strongly
suggests that the receptor-stimulated production of cAMP is
not altered in the mutants. The increased accumulation of
extracellular cAMP indicates that, by deleting the cAMP-
PDE activity of GbpB, intracellular cAMP is not effectively
degraded and more cAMP is available for secretion. Because
in wild-type cells 50% of the produced cAMP is degraded
intracellularly, complete inhibition of this degradation
would induce not more than a twofold increase of the cAMP
response.
GbpA does not hydrolyze cAMP, but may affect the cAMP
response indirectly, because the enzyme regulates cGMP
levels, and cGMP activates the cAMP-PDE activity of GbpB.
Consistent with this notion, we observed that the extracel-
lular cAMP accumulation in gbpA cells is reduced 50%
relative to cAMP accumulation in wild-type cells. The initial
cAMP accumulation rate is unaffected (0.33  0.09 pmol/s),
but the accumulation plateaus to a lower level (9.5  1.1
pmol), suggesting that the same amount of cAMP is pro-
duced but less cAMP is available for secretion.
Overexpression of GbpB leads to a very strong reduction
of the cAMP response, basal levels are decreased to 0.3 0.2
pmol, 12% from wild-type cells, and the cAMP accumula-
tion is only 1.2  0.2 pmol, which is only 6% of the response
seen in wild-type cells. The results suggest that GbpB is an
important PDE to modulate intracellular cAMP levels. Null
cells show increased cAMP levels, whereas overexpression
leads to a strong reduction of cAMP.
Phenotypes of gbpA and gbpB Mutants
Cell aggregation of gbpA cells, gbpB cells, and gbpA/
gbpB cells is normal compared with wild-type cells (our
unpublished data). The aggregation time is not different
from wild-type cells, and fruiting bodies have a relatively
normal size. Overexpression of GbpB (gbpA/gbpB/gbpBOE
cells) leads to very slow and poor aggregation (Figure 9).
Cell aggregation in wild type starts at 8 h and fruiting body
formation is completed after 20 h. The gbpAB/gbpBOE
cells start to aggregate at 12 h after the onset of starvation,
and slugs are first visible after 15 h, which is at least 4 h later
than in wild-type cells. Eventually, fruiting bodies are
formed after 27 h, but many cells do not participate in
multicellular development.
The phenotype of GbpB overexpression is similar to the
phenotype of overexpression of RegA, the first characterized
intracellular cAMP-PDE in Dictyostelium (Shaulsky et al.,
1998; Thomason et al., 1998). Deletion of the regA gene has
Figure 8. cGMP and cAMP responses in gbp mutant cells. The cell were starved for 5 h followed by stimulation with 0.1 M cAMP for
the cGMP response (A and B) and with 10 M 2-deoxy-cAMP and 10 mM dithiotreitol for the cAMP response (C). The symbols refer to
wild-type DH1 (); gbpA (‚); gbpB (e); gbpA/gbpB (f), and gbpA/gbpB/GbpBOE (E). Identical data are presented for wild-type DH1,
gbpB, and gbpA/gbpB/GbpBOE in A and B. The results shown are the means of triplicate determinations from a typical experiment repeated
once. The data in panel A were derived, in part, from Bosgraaf et al. (2002).
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been shown to lead to increased intracellular cAMP levels,
leading to a sporogenous phenotype: spores are formed in
the multicellular stage earlier than in the wild type, and
extracellular cAMP can induce spore formation in monolay-
ers of regA cells under buffer. We tested whether deletion
of GbpB, the second cAMP-PDE in addition to regA, also
leads to a sporogeneous phenotype (Table 1). Wild-type cells
did not form spores when incubated with cAMP in sub-
merged conditions. In contrast, a significant fraction of
gbpB and gbpA/gbpB cells had form spores. This was not
observed for the gbpA cells, indicating that the sporoge-
nous phenotype is specific for deletion of a cAMP-PDE
activity.
DISCUSSION
Two families of cyclic nucleotide phosphodiesterases have
been recognized in eukaryotes, the ubiquitous class I phos-
phodiesterases present in essentially all eukaryotes and the
small family of class II enzymes found in some bacteria,
several yeast species, and Dictyostelium (the surface cAMP-
phosphodiesterase PsdA). The class II enzymes belong to the
superfamily of proteins with a Zn2-binding hydrolase fold
that also includes -lactamases, glyoxylases, and arylsulfa-
tases (Carfi et al., 1995). The GbpA and GbpB enzymes
described in this report are phosphodiesterases and mem-
bers of the superfamily, but sequence alignment and phy-
logeny suggest that they are not very closely related to the
subfamily of class II phosphodiesterases (Goldberg et al.,
2002; our unpublished data). The domain programs SMART
and Pfam support this notion, because they recognize GbpA
and GbpB as -lactamases, but not as class II phosphodies-
terases.
Inactivation and overexpression of the gbpA and gbpB
genes indicate that gbpA encodes the cGMP-stimulated
cGMP-specific phosphodiesterase characterized previously
at a biochemical level (Van Haastert and Van Lookeren
Campagne, 1984), whereas gbpB encodes a novel cAMP/
cGMP-stimulated dual-specificity enzyme. Using about 20
cGMP analogs to characterize GbpA, it was demonstrated
that the cyclic nucleotide specificity for activation and hy-
drolysis are very different, which was regarded as strong
evidence that the enzyme possesses different cGMP-binding
sites for activation and catalysis (Kesbeke et al., 1985). The
domain structure of GbpA supports this hypothesis, because
the enzyme is composed of a Zn2-binding hydrolase fold,
likely mediating hydrolysis of cGMP, and two cNB domains
of which one is predicted to be a cGMP-binding regulatory
domain. The kinetic properties of GbpA are summarized in
Table 2, showing half-maximal activation at 0.16 M cGMP,
and a KM value of 5–20 M cGMP for the cGMP-activated
Figure 9. Phenotype of GbpBOE mutant cells. GbpB was overexpressed in gbpA/gbpB cells reaching an activity that was 50-fold higher
than GbpB activity of wild-type cells. Photographs show the phenotypes at different times after starvation; the inset shows normal spore
formation after 27 h in gbpA/gbpB/gbpBOE cells.
Table 1. Spore formation in gbp mutants
Strain No. of viable spores




Cells were incubated under buffer with cAMP for 36 h, treated with
0.5% NP-40 to kill amoebae, and plated in association with bacteria.
The figures refer to the number of colonies obtained in two exper-
iments, each derived from the original 4000 amoebae.
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and -nonactivated enzyme, respectively. GbpA does not
hydrolyze cAMP and is not stimulated by cAMP.
The biochemical phenotype of the gbpA cells is very
similar to that of the chemically mutated Dictyostelium stmF
cell line, which both lacks the same cGMP-stimulated PDE
activity (Ross and Newell, 1981; Van Haastert et al., 1982b).
Two alleles of stmF are known, NP368 that lacks all GbpA-
PDE activity, and NP377 that shows 5% of wild-type ac-
tivity with altered KM for cGMP and altered KA for 8-bromo-
cGMP (Van Haastert et al., 1982b; Coukell and Cameron,
1986). Therefore, we expected a severe mutation in NP368
leading to the absence of GbpA-PDE activity and a more
subtle mutation in the open reading frame of NP377, leading
to reduced and altered activity. Unexpectedly, we and
Meima et al. (2002) have not been able to identify a DNA
mutation in the gbpA gene of NP368 and NP377, respec-
tively. NP368 shows normal mRNA levels for gbpA. The
5-untranslated region of gbpA from NP368 was cloned be-
tween the actin promotor and GFP and did not reduce the
expression of green fluorescent protein. The complete
genomic copy of gbpA from NP368 was amplified and se-
quenced but did not reveal a mutation that would lead to
inactivation of the expressed enzyme (such as stop codons or
mutations in the proposed metal-binding catalytic site). We
observed a Gly-to-Asp mutation at position 69, far before the
proposed catalytic site; at this position the corresponding
GbpB sequence has an Asp (L.B., H.R., and P.V.H., unpub-
lished observations). Meima et al. (2002) observed reduced
gbpA transcript levels in NP377 but could not detect any
mutations in the promoter sequence.
The stmF mutants were originally isolated as “streamers,”
making large streams of aggregating cells. However, rever-
tants of the streamer phenotype have been shown still to be
defective in cGMP-PDE activity, indicating that the streamer
properties of stmF can be segregated from its altered cGMP-
PDE activity (Coukell and Cameron, 1986). Consistent with
this genetic analysis we did not observe a streamer pheno-
type in the cGMP-PDE–defective gbpA cells. StmF mutants
show an altered chemotaxis response during cell aggrega-
tion (Ross and Newell, 1981). However, wild-type cells
mixed with a large portion of stmF mutant cells chemotax as
mutant cells, whereas stmF cells mixed with a large portion
of wild-type cells behave essentially as wild-type cells
(Chandrasekhar et al., 1995). This suggests that the altered
aggregation behavior of stmF is due to an altered chemotaxis
signal rather than to a modified chemotaxis response. The
reduced cAMP relay in gbpA cells could explain this al-
tered aggregation of stmF mutants.
Table 2. Properties of six Dictyostelium PDEs
Phosphodiesterase PDE1 PDE2 PDE3 PDE4* PDE5 PDE6
Name of gene psdA regA DdPDE3 DdPDE4 gbpA gbpB
Localization Cell surface Cytosol Cytosol Cell surface Cytosol Cytosol
Class II I I I II II
cAMP/cGMP selectivity 3 200 0.0015 Unknown 0.003 9
cAMP hydrolysis
KM (M) 0.8 5 100 Unknown 500 200
(150) (1800)
VMAX (pmol/min/mg) 700 50 – Unknown – 5200
KA (M) – – – Unknown 300 0.7
AMAX – – – – – 1.47
cGMP hydrolysis
KM (M) 1.8 1000 0.22 –* 5.2–20 800
VMAX (pmol/min/mg) 490 – 2 –* 390 2400
KA (M) – – – –* 0.16 2.3
AMAX – – – – 2.40 1.86
Intracellular cAMP degradation
(pmol/min/mg)
0.1 M – 1 – –* – 2.6
1 M – 8 – –* – 26
5 M – 25 – –* – 127
Intracellular cGMP degradation
(pmol/min/mg)
0.1 M – – 0.6 –* 3.3 0.3
1 M – – 1.6 –* 48 3.0
5 M – – 1.9 –* 163 15
PDE4*, the enzyme has not been characterized biochemically; sequence data suggest that the enzyme is cAMP specific and has a signal
sequence and two transmembrane segments predicting the catalytic domain to be extracellular. The cAMP/cGMP selectivity refers to the
calculated VMAX/KM for cAMP divided by the VMAX/KM for cGMP. The data for the KM in parentheses refer to the cAMP concentration
inducing half-maximal inhibition of the hydrolysis of cGMP. The kinetic constants were derived from Van Haastert et al. (1983) for PDE1;
from Shaulsky et al. (1998) and Thomason et al. (1998) for PDE2, and from Figure 4 to calculate the VMAX in vivo, assuming that cAMP
hydrolysis in gbpA/gbpB is derived from RegA; for PDE6 from Kuwayama et al. (2001) for PDE3; from Figure 7 for PDE5; and from Figure
6 for PDE6. The rates of intracellular degradation were calculated using the obtained kinetic constants and are presented for three
concentrations representing basal levels (0.1 M), maximal levels in wild-type cells (1 M), and maximal levels in some deletion mutants (5
M).
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GbpB is characterized as a dual-specificity enzyme with
preference for cAMP; the enzyme is half-maximally acti-
vated by 2.3 M cGMP and 0.7 M cAMP, and hydrolyses
cGMP9-fold slower than cAMP. The catalytic site of GbpA
shows high affinity and high selectivity for cGMP (KM 	 5
M cGMP and KI 	 1800 M cAMP), whereas GbpB has a
much lower affinity and selectivity (KM	 800 M cGMP and
200 M cAMP). Experimental observations with cGMP an-
alogs have demonstrated that cGMP is bound in the catalytic
site of GbpA through a hydrogen bond to C6O, which can-
not be formed with cAMP (Kesbeke et al., 1985). It is con-
ceivable that this hydrogen bond potential is absent in GbpB
by which the affinity for cGMP is low and no strong dis-
crimination between cAMP and cGMP is possible in the
catalytic site. Similar differences in the activator sites of
GbpA and GbpB may explain the high affinity and selectiv-
ity of GbpA for cGMP relative to the nonspecific activation
of GbpB.
GbpA and GbpB are the fifth and sixth PDE enzymes
cloned in Dictyostelium. Therefore, these proteins may also
be addressed as DdPDE5 and DdPDE6, respectively1. The
Dictyostelium genome has been sequenced to 97% comple-
tion, suggesting that these six genes encode all phosphodi-
esterases in Dictyostelium, and we can begin with a detailed
analysis of the relative contribution and function of the
enzymes in modulating cAMP and cGMP levels in Dictyo-
stelium (Table 2). PDE1, encoded by the psdA gene, is a class
II nonselective enzyme located on the cell surface and in the
extracellular medium (Lacombe et al., 1986). PDE2, encoded
by the regA gene, is a cAMP-specific class I phosphodiester-
ase. The enzyme is located in the cytosol and is regulated by
a histidine kinase and cAMP-dependent protein kinase
(Shaulsky et al., 1998; Thomason et al., 1998). PDE3 is a
high-affinity, cGMP-specific enzyme located in the cytosol
(Kuwayama et al., 2001). PDE4 has not been characterized
biochemically, but the primary sequence predicts the en-
zyme to be cAMP specific; furthermore, a putative signal
sequence and two transmembrane segments are strongly
indicated by structure prediction programs, suggesting that
the enzyme is located at the plasma membrane with the
catalytic domain in the extracellular medium (S.B. and
P.V.H., unpublished observations). The six phosphodiester-
ases can be divided in three class I enzymes (PDE2, 3, and 4)
and three class II enzymes (PDE1, 5, and 6). It is intriguing
that GbpA shows similar biochemical properties as mam-
malian cGMP-stimulated phosphodiesterase, although the
protein sequences are completely different. The catalytic
domain of mammalian cGMP-stimulated phosphodiesterase
belongs to the large family of PDE class I enzymes, and the
cGMP-binding regulatory domain is unrelated to the cNB
domain of GbpA but belongs to the group of GAF domains
(Francis et al., 2000).
The cellular localization and cAMP/cGMP specificity of
the six Dictyostelium phosphodiesterases suggest three func-
tional groups: degradation of extracellular cAMP by PDE1
and PDE4, degradation of intracellular cAMP by PDE2 and
PDE6, and degradation of intracellular cGMP by PDE3,
PDE5, and PDE6. The estimated activities toward these sub-
strates in vivo may provide information on the relative
importance and functions of these enzymes. Because the
biochemical properties of PDE4 have not been determined
yet, the contribution of PDE4 in degradation of extracellular
cAMP is unknown.
Intracellular cAMP is degraded by the basal activity of
PDE2/RegA and PDE6/GbpB at approximately equal rates,
suggesting that both enzymes are important. This hypothe-
sis is supported by the observation that both regA and
gbpB null cells are sporogenous. The finding that RegA is
activated by cAMP-dependent protein kinase in vitro allows
strong modulation of RegA phosphodiesterase activity by
intracellular cAMP in vivo. Such modulation is also pre-
dicted for GbpB, which is activated by cAMP binding to its
activating cNB domain. The regA null cells may have a
stronger phenotype than gbpB null cells: regA aggregates
form multiple tips, whereas gbpB aggregates are as in
wild-type, and cAMP induces spore formation in 10% of
regA null cells vs. 1% of gbpB null cells. It is conceivable
that in vivo the activation of RegA by histidine kinase and
cAMP-dependent protein kinase is stronger than the activa-
tion of GbpB by cAMP. In conclusion, intracellular cAMP is
degraded by two complex phosphodiesterases that belong
to different classes of enzymes and show entirely different
mechanisms of regulation by cAMP.
Three enzymes participate in the degradation of intracel-
lular cGMP. The relative affinities and capacities clearly
demonstrate that PDE5/GbpA is the major cGMP-degrad-
ing enzyme in vivo. The high affinity but low capacity of
PDE3 predicts that this enzyme mainly participates in mod-
ulating low cGMP concentrations. In agreement with this
notion, we observed previously that PDE3 activity affects
basal cGMP levels but does not contribute much to the
degradation of the high cGMP levels that arise during stim-
ulation (Kuwayama et al., 2001). The cGMP-PDE activity of
PDE6/GbpB is also much smaller than the cGMP-PDE ac-
tivity of PDE5/GbpA. These relative cGMP-PDE activities
easily explain the effect of deletions of the three enzymes on
basal cGMP levels. Single knockouts of the small PDE3 and
PDE6 activities have little effect, whereas inactivation of the
high PDE5/GbpA activity strongly affects cGMP levels. In a
background of gbpA cells, PDE3 and PDE6 are the only
enzymes degrading cGMP, and have approximately equal
activity. Therefore, deletion of gbpB in a gbpA null back-
ground strongly increases cGMP levels. The function of
cGMP is closely associated with chemotaxis via regulation of
myosin II phosphorylation and myosin filament formation
(de la Roche and Cote, 2001). We have elaborated on a large
study toward the function of cGMP in myosin II regulation
and chemotaxis by using cGMP phosphodiesterase mutants,
also including double knockouts of the two guanylyl cycla-
ses GCA and sGC and double knockouts of the two cGMP
targets proteins GbpC and GbpD (Bosgraaf et al., 2002). The
results demonstrate enhanced myosin II phosphorylation
and filament formation in the gbpA/gbpB mutant with
elevated cGMP levels; this increased myosin phosphoryla-
1 The four previously recognized PDEs in Dictyostelium are as
follows: PDE1, the class II enzyme encoded by the psdA gene
(Lacombe et al., 1986); PDE2, the class I cAMP-specific enzyme
encoded by the regA gene (Shaulsky et al., 1998; Thomason et al.,
1998); PDE3, the class I cGMP-specific enzyme (Kuwayama et al.,
2001); and PDE4, a sequence recognized in the database (clone
JAX4b25f06.r1) coding for a class I putative phosphodiesterase;
the cGMP-stimulated cGMP-PDE activity is not affected by dis-
ruption of the PDE4 gene (S.B. and P.V.H., unpublished data).
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tion is associated with improved chemotaxis due to the
suppression of lateral pseudopodia. This phenotype of the
gbpA/gbpB mutant is consistent with the myosin and che-
motaxis phenotype of mutant stmF that also has elevated
cGMP levels (Liu and Newell, 1993; de la Roche and Cote,
2001).
In conclusion, we have identified novel cGMP- and
cAMP-regulated phosphodiesterases with a combination of
Zn2-hydrolase and cNB domains not observed before.
GbpA is a cGMP-stimulated cGMP-specific phosphodiester-
ase modulating cGMP levels, whereas GbpB is a dual-spec-
ificity phosphodiesterase with preference for cAMP modu-
lating intracellular cAMP levels involved in multicellular
development.
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